Currently out of the existing stock ratings of Michael Morabito, 16 are a BUY (94.12%), 1 are a HOLD (5.88%).

Michael Morabito

Work Performance Price Targets & Ratings Chart

Analyst Michael Morabito, currently employed carries an average stock price target met ratio of 40.28% that have a potential upside of 39.64% achieved within 215 days.

Michael Morabito’s has documented 36 price targets and ratings displayed on 8 stocks. The coverage was on Healthcare, Industrials sectors.

Most recent stock forecast was given on AXLA, Axcella Health at 02-Nov-2022.

Wall Street Analyst Michael Morabito

Analyst best performing recommendations are on MRTX (MIRATI THER).
The best stock recommendation documented was for MRTX (MIRATI THER) at 8/7/2020. The price target of $140 was fulfilled within 10 days with a profit of $11.12 (8.63%) receiving and performance score of 8.63.

Average potential price target upside

of $10.78 (150.96%) on VKTX (VIKING THERAPEUTICS).
of $10.35 (10.66%) on MRTX (MIRATI THER).
of $4.07 (4.11%) on ETN (EATON PLC).

DRRX Durect ETN Eaton PLC MRTX Mirati Ther VKTX Viking Therapeutics AXLA Axcella Health AKRO Akero Therapeutics CWBR CohBar ICPT Intercept Pharmaceuticals

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Francois Brisebois (OPPENHEIMER)